Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC News-Medical.net If endorsed by the European Commission, the recommendation would expand the indication for ZYTIGA®, which is currently approved for use in combination with prednisone/prednisolone to treat men with mCRPC whose disease has progressed on or after a ... BTG notes positive opinion in EU for ZYTIGA |
